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STRESZCZENIE
Migotanie przedsionków jest najczęstszą klinicznie istotną 
arytmią, której najcięższym powikłaniem jest udar mózgu. 
Z drugiej strony złożona terapia przeciwkrzepliwa, szczególnie 
u pacjentów starszych i „kruchych” pozostaje ogromnym wy-
zwaniem. Prezentujemy, według naszej wiedzy, pierwszy opis 
zabiegu jednoczasowego całkowicie torakoskopowego z uży-
ciem wizualizacji trójwymiarowej (3D), pomostowania naczyń 
wieńcowych (EACAB) i zamknięcia uszka lewego przedsionka. 
Słowa kluczowe: migotanie przedsionków, udar, 
antykoagulacja, uszko lewego przedsionka, zamknięcie, EACAB, 
torakoskopowo 3D
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ABSTRACT
Atrial fi brillation (AF) as the most prevalent arrhythmia has 
the most impact on morbidity and mortality. The worst com-
plication of AF is stroke. On the other hand, the double or triple 
antithrombotic therapy especially in fragile and elderly patients 
becomes a challenge. Here we present, to our knowledge 
the fi rst description of a simultaneous totally thoracoscopic 
three-dimensional (3D) augmented coronary artery bypass 
grafting and left atrial appendage occlusion.
Key words: atrial fi brillation, stroke, anticoagulation, left atrial 
appendage, occlusion, EACAB, thoracoscopic 3D
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Background
Atrial fi brillation (AF) as the highest prevalent ar-
rhythmia has the most impact on morbidity and 
mortality. In senescent human population it occurs 
concomitant to other heart diseases like coronary ar-
tery disease. The worst complication of AF is stroke. 
Approximately 90% of thromboembolic material 
originates from left atrial appendage (LAA). During 
classical coronary artery bypass grafting (CABG) 
there are many ways to exclude the LAA. However, 
recently minimally invasive coronary artery bypass 
grafting (MIDCAB) or even less invasive — endo-
scopic atraumatic coronary artery bypass grafting 
(EACAB) gain in feasibility and popularity. Here we 
would like to present fi rst totally thoracoscopic LAA 
occlusion during another thoracoscopic procedure, 
which was EACAB.
Materials and methods
89-year-old women with unstable coronary artery 
disease and persistent atrial fi brillation was admitted 
to our department after the Heart Team decision. 
Her medical history included previous stroke due 
to arrhythmia, heart failure and hypertension. Her 
CADS2-VASc Score was 7 and HAS-BLED Score 
was 4. Patient was placed in supine position with 
slightly elevated left side of the chest and under 
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/general anesthesia intubated with a double lumen 
intratracheal tube. A probe for transesophageal 
echocardiography (TEE) was introduced. On sin-
gle right lung ventilation 3 thoracoscopic ports 
were placed — one through the fourth intercostal 
space in anterior axillary line (for camera), and two 
through third and sixth intercostal spaces at the 
midaxillary line into the left pleura (working ports). 
Working space was created with CO2 insuffl ation. 
The 3D augmented endoscopic system (Einsten 
3D, Storz, Germany) was used. As a fi rst step left 
internal mammary artery (LIMA) was taken totally 
thoracoscopic with harmonic knife (Fig. 1). In second 
step pericardiectomy was performed parallel to the 
phrenic nerve to visualize the LAA and stay suture 
was placed on its lover edge to unveil LAA. The 
diameter of the base of the LAA was measured with 
dedicated selection guide. The AtriClip®PRO was 
introduced through the incision in sixth intercostal 
space enlarged to 3 cm and was deployed at the 
base of left atrium appendage under TEE control 
with special care not to leave stump. In third step 
3 cm left minithoracotomy in fi fth intercostal space 
under the mammary was done. After administration 
of adequate dose of heparin anastomosis between 
left anterior descending artery (LAD) and LIMA was 
performed. Perioperative period was uneventful. 
The patient was extubated 2 hours after the pro-
cedure. The total drainage was minimal — 200 ml. 
Chest tubes were taken out the next day. We ob-
served neither bleeding nor stroke complications. 
Due to high frailty score (7) patient was transferred 
on 7th postoperative day to further cardiological 
rehabilitation. Only aspirin was prescribed from 
day O.
Discussion
The expected length of life in developed countries is 
still rising due to more effective health care system. 
However, it is connected with higher and multiple 
comorbidity and higher frailty score of patients 
referred to surgical treatment. The most common 
structural heart disease is coronary artery disease, 
and the most common arrhythmia is atrial fi brillation. 
Moreover, the fi rst one is the risk factor of the second 
one. As the frequency of both illnesses rises with 
the age, cardiology and cardiac surgery is facing 
the rising number of patients with coronary artery 
disease concomitant to atrial fi brillation. The most 
important aspect of therapy of AF is stroke preven-
tion, especially in elderly patients in which ablation 
is connected with higher risk of complications and 
failure. The necessity of complex antithrombotic 
therapy is a huge challenge leading in such a group 
of patients to signifi cant number of major, often fatal 
complications [1].
Recently more data shows signifi cant profi ts with 
LAA occlusion in stroke prevention in patients with 
atrial fi brillation [2]. The most important question is 
about the most effective and safe way to exclude 
the LAA. It was prove that its incomplete occlusion 
is even higher risk factor for thromboembolic events 
than leaving it open [3]. The technique should be 
both safe for the patient and effective in closing 
the connection between atrium and LAA without 
residual stump. 
Here presented AtriClip (Atricure, USA) used in 
terms of fi rst experience with LAA occlusion during 
minimally invasive coronary artery bypass grafting 
is promising and recently one of the most effective 
systems for LAA exclusion in patients with atrial 
fi brillation. The available data shows up to 100% 
effi cacy both in short and long-term observation 
over few years [4–8]. Furthermore no early or late 
complications have been revealed over the time of 
3 years [9]. The most important is that during this 
period no stroke was observed event though the 
mean CHADS2VASC Score was 4 (about 10% of 
yearly stroke risk) and half of the patients was off 
oral anticoagulation therapy [9]. A singifi camt clin-
ical advantage in such patients is that aspirin could 
Figure 1. Thoracoscopic LIMA harvesting using 3D augmented 
endoscopy.
Figure 2. Thoracoscopic left atrial appendage occlusion using a clipping 
device (3D augmented endoscopy)
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16 be given right away without any dual antiplatelet 
therapy bridging.
Traditionally complex heart operations are connected 
with full sternotomy which may signifi cantly weaken 
vital forces of older patients, delay the recovery 
or even discourage from undertaken the risk of 
recommended surgical treatment. This concerns 
led to more dynamic progress in developing the 
minimally invasive and hybrid techniques in cardiac 
surgery and cardiology in order to balance the pros 
and cons and not to refuse this group of patients 
the optimal treatment.
Here presented approach allowed not only to omit 
the sternotomy but also using video-assisted totally 
thoracoscopic techniques to harvest the LIMA and 
deploy the AtriClip to reduce the traumatization of the 
chest. The postoperative rehabilitation and recovery 
was faster and less problematic for the elder patient. 
As the limitations of the procedure should be men-
tioned the very limited but still invasiveness. The 
objective contraindication for the totally thoraco-
scopic LAA clipping is the presence of thrombus 
within the LAA. The subjective contraindications for 
thoracoscopic access are the history of the operation 
within pericardium and/or left pleural cavity.
Conclusion
The above presented case is to our knowledge the 
fi rst described simultaneous totally thoracoscopic 
coronary artery bypass grafting and left atrial ap-
pendage occlusion. Such treatment offers the elderly 
patients minimal surgical injury, diminish the risk 
of delayed rehabilitation and wound healing with 
signifi cant health benefi ts like revascularization and 
secondary prevention of stroke, avoiding complex 
antithrombotic therapy.
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